Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -142,494 | -85,037 | -41,640 | -292,963 | -212,714 |
| Depreciation Amortization | -660 | -577 | -92 | -797 | -856 |
| Accounts payable and accrued liabilities | -6,887 | -8,758 | -3,810 | 9,526 | 256 |
| Other Working Capital | -18,450 | -28,783 | -17,026 | 14,874 | 9,586 |
| Other Operating Activity | 25,525 | 20,699 | 9,513 | 158,566 | 134,994 |
| Operating Cash Flow | $-142,966 | $-102,456 | $-53,055 | $-110,794 | $-68,734 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 76,734 | -48,266 | 15,000 | -31,555 | -42,688 |
| PPE Investments | -5,686 | -4,570 | -3,665 | -7,173 | -6,047 |
| Other Investing Activity | -6,246 | -6,246 | -6,246 | -46,335 | -46,086 |
| Investing Cash Flow | $64,802 | $-59,082 | $5,089 | $-85,063 | $-94,821 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 219,236 | 172,928 | 172,713 | 255,757 | 235,272 |
| Other Financing Activity | -11,674 | -10,755 | -10,485 | -15,228 | -14,828 |
| Financing Cash Flow | $207,562 | $162,173 | $162,228 | $240,529 | $220,444 |
| Beginning Cash Position | 143,451 | 143,451 | 143,451 | 98,779 | 98,779 |
| End Cash Position | 272,849 | 144,086 | 257,713 | 143,451 | 155,668 |
| Net Cash Flow | $129,398 | $635 | $114,262 | $44,672 | $56,889 |
| Free Cash Flow | |||||
| Operating Cash Flow | -142,966 | -102,456 | -53,055 | -110,794 | -68,734 |
| Capital Expenditure | -5,686 | -4,570 | -3,665 | -7,173 | -6,047 |
| Free Cash Flow | -148,652 | -107,026 | -56,720 | -117,967 | -74,781 |